DexCom Inc (DXCM)

73.40 +0.44%

DexCom Inc (DXCM) is currently trading at $73.40. This represents a gain of 0.44% from the previous session. With a market capitalization of $28.31B, DXCM is a key component of the Health Care sector. Investors looking to trade DXCM should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade DXCM commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, DexCom Inc (DXCM) shows a bullish trend. Analysts are watching the 73.71 level closely.

Fundamentals
Mkt Cap28.31B
P/E Ratio0.0000
Volume2,035,768
Others Watching (By Market Cap)
CAH
Cardinal Health $226.44
+0.23% IDXX
IDEXX Laborator $657.93
+1.34% BDX
Becton Dickinso $180.96
-0.96% EW
Edwards Lifesci $83.45
+1.26% ALNY
Alnylam Pharmac $328.46
-1.66%
60-Day Technical Chart
Advanced Charting

Need more indicators for DXCM? Use the world's #1 platform.

Open DXCM on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $73
Metric DXCM
+0.44% 		HOOD
+5.44% 		UBER
+1.95% 		CSCO
+1.23%
Price $73.40 $77.32 $72.73 $79.10
Mkt Cap $28.31B $69.69B $149.91B $312.69B
- View → View → View →
Latest Headlines
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars The Motley Fool • Feb 25, 2026 How to watch Dexcom’s Raymond James investor conference update Stock Titan • Feb 25, 2026 Assessing DexCom (DXCM) Valuation After Short Term Gains And A 14.5% Undervaluation Narrative simplywall.st • Feb 25, 2026 BTIG Reiterates Buy Rating on DXCM with $85 Target | DXCM Stock News GuruFocus • Feb 25, 2026 Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars The Globe and Mail • Feb 25, 2026
● Gemini Agentic AI Analyst Insight for DXCM
Market Education
View All Articles →
External Research